IE
ACIU icon

Israel Englander’s AC Immune ACIU Stock Holding History

Israel Englander’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.84M Sell
773,594
-19,063
-2% -$52.5K ﹤0.01% 3888
2026
Q1 		$2.18M Sell
792,657
-140,685
-15% -$437K ﹤0.01% 3797
2025
Q4 		$2.93M Buy
933,342
+38,810
+4% +$122K ﹤0.01% 3585
2025
Q3 		$2.59M Buy
894,532
+603,000
+207% +$1.36M ﹤0.01% 3807
2025
Q2 		$592K Buy
291,532
+78,782
+37% +$137K ﹤0.01% 4787
2025
Q1 		$398K Buy
212,750
+93,710
+79% +$236K ﹤0.01% 4941
2024
Q4 		$321K Sell
119,040
-47,100
-28% -$147K ﹤0.01% 5036
2024
Q3 		$628K Buy
166,140
+59,777
+56% +$209K ﹤0.01% 4647
2024
Q2 		$424K Buy
+106,363
New +$352K ﹤0.01% 4691
2023
Q3 		– Sell
-51,532
Closed -$152K – 6058
2023
Q2 		$152K Sell
51,532
-67,495
-57% -$147K ﹤0.01% 5220
2023
Q1 		$279K Buy
119,027
+10,221
+9% +$23.7K ﹤0.01% 4962
2022
Q4 		$222K Buy
+108,806
New +$280K ﹤0.01% 5271
2021
Q4 		– Sell
-40,452
Closed -$271K – 6700
2021
Q3 		$271K Sell
40,452
-36,117
-47% -$259K ﹤0.01% 5884
2021
Q2 		$607K Sell
76,569
-175,457
-70% -$1.21M ﹤0.01% 5132
2021
Q1 		$1.92M Buy
252,026
+230,886
+1,092% +$1.65M ﹤0.01% 3581
2020
Q4 		$109K Sell
21,140
-252,989
-92% -$1.29M ﹤0.01% 5004
2020
Q3 		$1.34K Sell
274,129
-243,107
-47% -$1.74M ﹤0.01% 2918
2020
Q2 		$3.48M Sell
517,236
-8,443
-2% -$61.4K ﹤0.01% 2089
2020
Q1 		$3.63M Buy
525,679
+475,701
+952% +$3.72M 0.01% 1587
2019
Q4 		$426K Sell
49,978
-72,828
-59% -$485K ﹤0.01% 3480
2019
Q3 		$607K Sell
122,806
-103,168
-46% -$553K ﹤0.01% 3129
2019
Q2 		$1.25M Buy
225,974
+56,215
+33% +$286K ﹤0.01% 2670
2019
Q1 		$857K Buy
+169,759
New +$1.08M ﹤0.01% 2956
2017
Q2 		– Sell
-122,924
Closed -$1.27M – 3405
2017
Q1 		$1.27M Buy
122,924
+49,394
+67% +$606K ﹤0.01% 2259
2016
Q4 		$954K Buy
73,530
+21,409
+41% +$296K ﹤0.01% 2274
2016
Q3 		$858K Buy
+52,121
New +$901K ﹤0.01% 2343

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Israel Englander's ACIU Position: Q2 2026 in Review

Israel Englander reduced its AC Immune (ACIU) stake by 2.4% in Q2 2026, selling an estimated $52.5K and leaving 773,594 shares worth $1.84M. The position accounts for ﹤0.01% of the portfolio, ranked #3888.

Israel Englander first reported a position in ACIU in Q3 2016 and has held it in 26 quarters since. The position peaked at $3.63M in Q1 2020. 43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • Israel Englander held 773,594 shares of AC Immune worth $1.84M as of Q2 2026.
  • Israel Englander sold 19,063 AC Immune shares in Q2 2026, an estimated $52.5K.
  • AC Immune made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3888 holding.
  • Israel Englander first reported a position in AC Immune in Q3 2016 and has held it in 26 quarters since.
  • Israel Englander's AC Immune position peaked at $3.63M in Q1 2020.
  • 43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.